首页> 美国卫生研究院文献>Infection and Immunity >Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.
【2h】

Contribution of antibody in normal human serum to early deposition of C3 onto encapsulated and nonencapsulated Cryptococcus neoformans.

机译:正常人血清中的抗体对C3早期沉积到封装和未封装的新型隐球菌中的贡献。

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Encapsulated and nonencapsulated cryptococci differ in their activation of the complement system. Incubation of nonencapsulated cryptococci in normal human serum (NHS) initiates both the classical and alternative pathways. This activation is characterized by an immediate, synchronous activation and binding of C3 to the yeast cells. Encapsulated cryptococci activate only the alternative pathway. This activation is characterized by a delayed (4 to 5 min), asynchronous activation and binding of C3. We examined the properties of antibodies in NHS that mediate immediate, synchronous binding of C3 to nonencapsulated cryptococci and zymosan. Adsorption of NHS with nonencapsulated cryptococci or zymosan produced a 4- to 6-min delay in the kinetics for activation and binding of C3 from the adsorbed serum to each respective yeast cell. This delay was similar to the delay observed when nonencapsulated cryptococci or zymosan was incubated in NHS in which the classical pathway was blocked by chelation of Ca2+. Proteins bound to serum-treated nonencapsulated cryptococci or zymosan were eluted and found to be predominantly immunoglobulin G (IgG), with lesser amounts of IgM. The eluted IgG could restore to adsorbed serum the rapid early kinetics for activation and binding of C3 characteristic of classical pathway initiation. Cross-adsorption showed that there was considerable cross-reactivity between the antibodies which restored rapid, early activation kinetics to NHS adsorbed with zymosan or nonencapsulated cryptococci. Encapsulated cryptococci were unable to adsorb the antibodies from NHS that mediated the rapid, early activation and binding of C3 to zymosan and nonencapsulated cryptococci. The latter results show that occlusion of antigenic sites at the cryptococcal cell wall is a newly recognized property that can be added to the repertoire of biological activities of the cryptococcal capsule.
机译:封装和非封装的隐球菌在补体系统的激活方面有所不同。未包囊的隐球菌在正常人血清(NHS)中的孵育可引发经典途径和替代途径。这种激活的特征是立即,同步激活和C3与酵母细胞结合。封装的隐球菌仅激活替代途径。这种激活的特点是延迟(4至5分钟),异步激活和C3绑定。我们检查了NHS中介导C3与未包囊的隐球菌和酵母聚糖的即时,同步结合的抗体的性质。非包囊隐球菌或酵母聚糖对NHS的吸附在动力学上延迟了4到6分钟,以激活和吸附C3从吸附的血清到各个酵母细胞的结合。此延迟类似于将未封装的隐球菌或酵母聚糖在NHS中孵育时所观察到的延迟,在NHS中经典途径被Ca2 +的螯合所阻断。洗脱与血清处理的未包囊隐球菌或酵母聚糖结合的蛋白质,发现主要是免疫球蛋白G(IgG),IgM量较少。洗脱的IgG可以恢复吸附的血清的快速早期动力学,以激活和结合经典途径起始的C3特征。交叉吸附表明,抗体之间存在相当大的交叉反应性,可将其迅速,早期活化动力学恢复为用酵母聚糖或未包囊的隐球菌吸附的NHS。封装的隐球菌无法吸收NHS介导的C3与酵母聚糖和未封装的隐球菌的快速,早期活化和结合的抗体。后一结果表明,在隐球菌细胞壁上的抗原性位点的闭塞是一种新发现的特性,可以添加到隐球菌胶囊生物活性库中。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号